AMS pleased with CMS' increase in 2012 payment rate for proton therapy

NewsGuard 100/100 Score

AMERICAN SHARED HOSPITAL SERVICES (AMEX:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the recent announcement by the Centers for Medicare & Medicade Services (CMS) of a 15% increase in the payment rate of proton therapy for hospital based centers beginning in 2012 strengthens the economic case for the proton centers now under development by the Company. "We are pleased that CMS recognizes the therapeutic value of proton therapy, now widely regarded as the optimal radiation treatment for an increasing variety of cancers. This payment increase will facilitate the development of much-needed proton therapy centers throughout the country," said AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D.

“We are pleased that CMS recognizes the therapeutic value of proton therapy, now widely regarded as the optimal radiation treatment for an increasing variety of cancers. This payment increase will facilitate the development of much-needed proton therapy centers throughout the country”

AMS is developing hospital based proton therapy centers in Boston (Tufts Medical Center), Orlando (Orlando Regional Healthcare) and Long Beach, California (Long Beach Memorial Medical Center).

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer